Get started
Author

Robert A. Zollo

Observed names: R. Zollo, ROBERT A ZOLLO, Robert Zollo
ORCID: 0000-0001-5415-4855
Observed ORCID: 0000-0001-5415-4855
OpenAlex ID: A5044400772
Visceral Obesity Promotes Lung Cancer Progression—Toward Resolution of the Obesity Paradox in Lung Cancer
2021 · Joseph Barbi, Santosh K. Patnaik, et al. · Journal of Thoracic Oncology · 75
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
2022 · Sean H. Colligan, Andrea M. Amitrano, et al. · Journal of Clinical Investigation · 49
PDF
Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin
2024 · Randall J Smith, Robert Zollo, et al. · JNCI Journal of the National Cancer Institute · 14
PDF
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction
2023 · Randall Smith, Sai Yendamuri, et al. · ERJ Open Research · 3
PDF
Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction
2026 · Joseph Barbi, Randall J. Smith, et al. · Journal of Thoracic Oncology · 2
PDF
Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models
2022 · Randall Smith, Leila Zabihi Diba, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Exercise Modulates Adiposity-induced Immune Dysfunction in NSCLC and Non-tumor–Bearing Lungs: Implications for Lung Cancer Therapy and Interception
2026 · Randall Smith, Kayleigh Erickson, et al. · Annals of Surgery
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer
2025 · Priyanka Rajan, Robert Zollo, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
971 Metformin improves anti-tumor immunity, lung cancer outcomes, and immunotherapy response specifically in the context of obesity
2024 · Joseph Barbi, Randall Smith, et al. · Regular and Young Investigator Award Abstracts
Abstract 5536: The role of p38 MAPK in the tumor-induced immune suppressive microenvironment in metastatic breast cancer
2024 · Priyanka Rajan, Robert Zollo, et al. · Cancer Research
Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models
2023 · Joseph J Barbi, Randall Smith, et al. · The Journal of Immunology
PDF
Abstract 73: Blockade of p38 MAPK reduces the tumor-induced immune suppressive microenvironment in metastatic breast cancer
2023 · Priyanka Rajan, Justin Zonneville, et al. · Cancer Research
Immunoprofiling Bal Reveals Obesity-associated Immune Dysfunction
2022 · RANDALL J SMITH, SAIKRISHNA S. YENDAMURI, et al. · CHEST Journal
Dynamic Phosphorylation Regulates Eukaryotic Translation Initiation Factor 4A Activity During the Cell Cycle
2022 · Ansuman Sahoo, Robert A. Zollo, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 2082: Obesity dependent benefits of metformin for improved anti-tumor immunity and outcomes in non-small cell lung cancer
2022 · Joseph Barbi, Randall J. Smith, et al. · Cancer Research
OA12.02 Metformin has Divergent Effects on the Tumor Immune Microenvironment of Non-Small Cell Lung Cancer (NSCLC) Depending on Obesity
2021 · J. Barbi, R. Zollo, et al. · Journal of Thoracic Oncology
Metformin corrects immune dysfunction and modulates tumor gene expression in overweight individuals to yield context-specific improvement of lung cancer outcomes
2020 · Joseph J Barbi, Robert Zollo, et al. · The Journal of Immunology
Works count: 18
Citation count: 144
H-index: 3
I10-index: 3
Year
Topic
Type